Evidence map›Paper›PMID 38639729›Full record

Trial reportJAMA2024

Stewardship Prompts to Improve Antibiotic Selection for Pneumonia: The INSPIRE Randomized Clinical Trial.

Shruti K Gohil, Edward Septimus, Ken Kleinman, Neha Varma, Taliser R Avery, Lauren Heim, Risa Rahm, William S Cooper, Mandelin Cooper, Laura E McLean and 30 more

Registry-linked trialAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in JAMA, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03697070 (INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection for Patients With Pneumonia), which is not on this map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03697070 nacompletednot on this map

INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection for Patients With Pneumonia

TypeinterventionalSponsorHarvard Pilgrim Health CareRan2018 to 2024Enrolled44,780ConditionsPneumoniaArmsINSPIRE CPOE Smart Prompt, Routine Care
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. [Requirements for the rational use of antibiotics based on antibiotic stewardship].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2026
    Review
  9. Review
  10. Review
  11. Article
  12. The institutional antibiogram: Time for a makeover?Journal of hospital medicine · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

40 authors.

Shruti K GohilDivision of Infectious Diseases, University of California, Irvine School of Medicine, Irvine.
Edward SeptimusDepartment of Population Medicine, Harvard Pilgrim Healthcare Institute, Harvard Medical School, Boston, Massachusetts.
Ken KleinmanBiostatistics and Epidemiology, University of Massachusetts, Amherst.
Neha VarmaDepartment of Population Medicine, Harvard Pilgrim Healthcare Institute, Boston, Massachusetts.
Taliser R AveryDepartment of Population Medicine, Harvard Pilgrim Healthcare Institute, Harvard Medical School, Boston, Massachusetts.
Lauren HeimDivision of Infectious Diseases, University of California, Irvine School of Medicine, Irvine.
Risa RahmHCA Healthcare, Nashville, Tennessee.
William S CooperHCA Healthcare, Nashville, Tennessee.
Mandelin CooperHCA Healthcare, Nashville, Tennessee.
Laura E McLeanHCA Healthcare, Nashville, Tennessee.
Naoise G NickolayHCA Healthcare, Nashville, Tennessee.
Robert A WeinsteinRush University Medical Center, Cook County Health, Chicago, Illinois.
L Hayley BurgessHCA Healthcare, Nashville, Tennessee.
Micaela H CoadyDepartment of Population Medicine, Harvard Pilgrim Healthcare Institute, Boston, Massachusetts.
Edward RosenDepartment of Population Medicine, Harvard Pilgrim Healthcare Institute, Boston, Massachusetts.
Selsebil SljivoDepartment of Population Medicine, Harvard Pilgrim Healthcare Institute, Boston, Massachusetts.
Kenneth E SandsDepartment of Population Medicine, Harvard Pilgrim Healthcare Institute, Harvard Medical School, Boston, Massachusetts.
Julia MoodyHCA Healthcare, Nashville, Tennessee.
Justin VigeantDepartment of Population Medicine, Harvard Pilgrim Healthcare Institute, Boston, Massachusetts.
Syma RashidDivision of Infectious Diseases, University of California, Irvine School of Medicine, Irvine.
Rebecca F GilbertDepartment of Population Medicine, Harvard Pilgrim Healthcare Institute, Boston, Massachusetts.
Kim N SmithHCA Healthcare, Nashville, Tennessee.
Brandon CarverHCA Healthcare, Nashville, Tennessee.
Russell E PolandDepartment of Population Medicine, Harvard Pilgrim Healthcare Institute, Harvard Medical School, Boston, Massachusetts.
Jason HickokHCA Healthcare, Nashville, Tennessee.
S G SturdevantNational Institutes of Health, Bethesda, Maryland.
Michael S CalderwoodSection of Infectious Disease and International Health, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire.
Anastasiia WeilandDivision of Infectious Diseases, University of California, Irvine School of Medicine, Irvine.
David W KubiakBrigham and Women's Hospital, Boston, Massachusetts.
Sujan ReddyCenters for Disease Control and Prevention, Atlanta, Georgia.
Melinda M NeuhauserCenters for Disease Control and Prevention, Atlanta, Georgia.
Arjun SrinivasanCenters for Disease Control and Prevention, Atlanta, Georgia.
John A JerniganCenters for Disease Control and Prevention, Atlanta, Georgia.
Mary K HaydenRush University Medical Center, Chicago, Illinois.
Abinav GowdaDepartment of Population Medicine, Harvard Pilgrim Healthcare Institute, Boston, Massachusetts.
Katyuska EibensteinerDepartment of Population Medicine, Harvard Pilgrim Healthcare Institute, Boston, Massachusetts.
Robert WolfDepartment of Population Medicine, Harvard Pilgrim Healthcare Institute, Boston, Massachusetts.
Jonathan B PerlinHCA Healthcare, Nashville, Tennessee.
Richard PlattDepartment of Population Medicine, Harvard Pilgrim Healthcare Institute, Harvard Medical School, Boston, Massachusetts.
Susan S HuangDivision of Infectious Diseases, University of California, Irvine School of Medicine, Irvine.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Pneumonia is the most common infection requiring hospitalization and is a major reason for overuse of extended-spectrum antibiotics. Despite low risk of multidrug-resistant organism (MDRO) infection, clinical uncertainty often drives initial antibiotic selection. Strategies to limit empiric antibiotic overuse for patients with pneumonia are needed. Objective: To evaluate whether computerized provider order entry (CPOE) prompts providing patient- and pathogen-specific MDRO infection risk estimates could reduce empiric extended-spectrum antibiotics for non-critically ill patients admitted with pneumonia. Design, Setting, and Participants: Cluster-randomized trial in 59 US community hospitals comparing the effect of a CPOE stewardship bundle (education, feedback, and real-time MDRO risk-based CPOE prompts; n = 29 hospitals) vs routine stewardship (n = 30 hospitals) on antibiotic selection during the first 3 hospital days (empiric period) in non-critically ill adults (≥18 years) hospitalized with pneumonia. There was an 18-month baseline period from April 1, 2017, to September 30, 2018, and a 15-month intervention period from April 1, 2019, to June 30, 2020. Intervention: CPOE prompts recommending standard-spectrum antibiotics in patients ordered to receive extended-spectrum antibiotics during the empiric period who have low estimated absolute risk (<10%) of MDRO pneumonia, coupled with feedback and education. Main Outcomes and Measures: The primary outcome was empiric (first 3 days of hospitalization) extended-spectrum antibiotic days of therapy. Secondary outcomes included empiric vancomycin and antipseudomonal days of therapy and safety outcomes included days to intensive care unit (ICU) transfer and hospital length of stay. Outcomes compared differences between baseline and intervention periods across strategies. Results: Among 59 hospitals with 96 451 (51 671 in the baseline period and 44 780 in the intervention period) adult patients admitted with pneumonia, the mean (SD) age of patients was 68.1 (17.0) years, 48.1% were men, and the median (IQR) Elixhauser comorbidity count was 4 (2-6). Compared with routine stewardship, the group using CPOE prompts had a 28.4% reduction in empiric extended-spectrum days of therapy (rate ratio, 0.72 [95% CI, 0.66-0.78]; P < .001). Safety outcomes of mean days to ICU transfer (6.5 vs 7.1 days) and hospital length of stay (6.8 vs 7.1 days) did not differ significantly between the routine and CPOE intervention groups. Conclusions and Relevance: Empiric extended-spectrum antibiotic use was significantly lower among adults admitted with pneumonia to non-ICU settings in hospitals using education, feedback, and CPOE prompts recommending standard-spectrum antibiotics for patients at low risk of MDRO infection, compared with routine stewardship practices. Hospital length of stay and days to ICU transfer were unchanged. Trial Registration: ClinicalTrials.gov Identifier: NCT03697070.

Indexed as

Anti-Bacterial AgentsAntimicrobial StewardshipPneumoniaAgedAged, 80 and overDrug Resistance, Multiple, BacterialFemaleHospitalizationHumansMaleMedical Order Entry SystemsMiddle AgedPneumonia, BacterialUnited StatesAnti-Bacterial Agents

Identifiers

PMID38639729
PMCPMC11185977

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.